nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—thyroid cancer	0.232	1	CrCtD
Epirubicin—Anthracyclines—Doxorubicin—thyroid cancer	0.188	0.657	CiPCiCtD
Epirubicin—bone cancer—thyroid cancer	0.134	1	CtDrD
Epirubicin—Topoisomerase Inhibitors—Doxorubicin—thyroid cancer	0.0981	0.343	CiPCiCtD
Epirubicin—Idarubicin—Doxorubicin—thyroid cancer	0.0493	0.333	CrCrCtD
Epirubicin—Daunorubicin—Doxorubicin—thyroid cancer	0.0493	0.333	CrCrCtD
Epirubicin—Valrubicin—Doxorubicin—thyroid cancer	0.0493	0.333	CrCrCtD
Epirubicin—AURKA—Doxorubicin—thyroid cancer	0.0369	0.276	CbGbCtD
Epirubicin—YWHAG—Doxorubicin—thyroid cancer	0.0369	0.276	CbGbCtD
Epirubicin—DHCR7—Doxorubicin—thyroid cancer	0.0369	0.276	CbGbCtD
Epirubicin—ABCC1—Vandetanib—thyroid cancer	0.0114	0.085	CbGbCtD
Epirubicin—TOP2A—Doxorubicin—thyroid cancer	0.0075	0.0561	CbGbCtD
Epirubicin—ABCC1—Doxorubicin—thyroid cancer	0.00416	0.0311	CbGbCtD
Epirubicin—CHD1—saliva-secreting gland—thyroid cancer	0.000811	0.0911	CbGeAlD
Epirubicin—CHD1—trachea—thyroid cancer	0.000625	0.0703	CbGeAlD
Epirubicin—DHCR7—saliva-secreting gland—thyroid cancer	0.000547	0.0614	CbGeAlD
Epirubicin—YWHAG—saliva-secreting gland—thyroid cancer	0.000501	0.0564	CbGeAlD
Epirubicin—CHD1—thyroid gland—thyroid cancer	0.000495	0.0556	CbGeAlD
Epirubicin—CHD1—head—thyroid cancer	0.000439	0.0493	CbGeAlD
Epirubicin—DHCR7—trachea—thyroid cancer	0.000422	0.0474	CbGeAlD
Epirubicin—AURKA—thyroid gland—thyroid cancer	0.000399	0.0448	CbGeAlD
Epirubicin—YWHAG—trachea—thyroid cancer	0.000387	0.0435	CbGeAlD
Epirubicin—PLA2G4A—saliva-secreting gland—thyroid cancer	0.000374	0.042	CbGeAlD
Epirubicin—AURKA—head—thyroid cancer	0.000354	0.0397	CbGeAlD
Epirubicin—DHCR7—thyroid gland—thyroid cancer	0.000334	0.0375	CbGeAlD
Epirubicin—CHD1—lymph node—thyroid cancer	0.000307	0.0345	CbGeAlD
Epirubicin—YWHAG—thyroid gland—thyroid cancer	0.000306	0.0344	CbGeAlD
Epirubicin—DHCR7—head—thyroid cancer	0.000296	0.0333	CbGeAlD
Epirubicin—PLA2G4A—trachea—thyroid cancer	0.000289	0.0324	CbGeAlD
Epirubicin—YWHAG—head—thyroid cancer	0.000271	0.0305	CbGeAlD
Epirubicin—AURKA—lymph node—thyroid cancer	0.000248	0.0278	CbGeAlD
Epirubicin—PLA2G4A—thyroid gland—thyroid cancer	0.000228	0.0257	CbGeAlD
Epirubicin—TOP2A—thyroid gland—thyroid cancer	0.000217	0.0244	CbGeAlD
Epirubicin—DHCR7—lymph node—thyroid cancer	0.000207	0.0233	CbGeAlD
Epirubicin—YWHAG—lymph node—thyroid cancer	0.00019	0.0214	CbGeAlD
Epirubicin—CHD1—Daunorubicin—Doxorubicin—thyroid cancer	0.000172	0.213	CbGdCrCtD
Epirubicin—CHD1—Idarubicin—Doxorubicin—thyroid cancer	0.000172	0.213	CbGdCrCtD
Epirubicin—ABCC1—trachea—thyroid cancer	0.000165	0.0185	CbGeAlD
Epirubicin—PLA2G4A—lymph node—thyroid cancer	0.000142	0.0159	CbGeAlD
Epirubicin—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.000138	0.171	CbGdCrCtD
Epirubicin—TOP2A—lymph node—thyroid cancer	0.000135	0.0151	CbGeAlD
Epirubicin—ABCC1—thyroid gland—thyroid cancer	0.000131	0.0147	CbGeAlD
Epirubicin—TOP2A—Afatinib—Vandetanib—thyroid cancer	9e-05	0.112	CbGdCrCtD
Epirubicin—ABCC1—lymph node—thyroid cancer	8.11e-05	0.00912	CbGeAlD
Epirubicin—TOP2A—Gefitinib—Vandetanib—thyroid cancer	7.87e-05	0.0975	CbGdCrCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—SST—thyroid cancer	6.72e-05	0.00453	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—BRAF—thyroid cancer	6.65e-05	0.00449	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—MINPP1—thyroid cancer	6.6e-05	0.00446	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	6.53e-05	0.00441	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—AKT1—thyroid cancer	6.52e-05	0.0044	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—CALCA—thyroid cancer	6.5e-05	0.00439	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	6.11e-05	0.00413	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—AKT1—thyroid cancer	5.87e-05	0.00396	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—thyroid cancer	5.84e-05	0.00394	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—PCM1—thyroid cancer	5.82e-05	0.00393	CbGpPWpGaD
Epirubicin—AURKA—Idarubicin—Doxorubicin—thyroid cancer	5.66e-05	0.0701	CbGdCrCtD
Epirubicin—AURKA—Daunorubicin—Doxorubicin—thyroid cancer	5.66e-05	0.0701	CbGdCrCtD
Epirubicin—DHCR7—Metabolism—NDUFA13—thyroid cancer	5.62e-05	0.00379	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	5.4e-05	0.00365	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CHST14—thyroid cancer	5.28e-05	0.00357	CbGpPWpGaD
Epirubicin—YWHAG—Insulin-mediated glucose transport—AKT1—thyroid cancer	5.21e-05	0.00352	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PCM1—thyroid cancer	5.2e-05	0.00351	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—thyroid cancer	4.97e-05	0.00336	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—thyroid cancer	4.96e-05	0.00335	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—HIF1A—thyroid cancer	4.86e-05	0.00328	CbGpPWpGaD
Epirubicin—AURKA—Integrin-linked kinase signaling—AKT1—thyroid cancer	4.84e-05	0.00327	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—TPR—thyroid cancer	4.69e-05	0.00317	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDK1—thyroid cancer	4.59e-05	0.0031	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—BRAF—thyroid cancer	4.58e-05	0.0031	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	4.52e-05	0.00305	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—thyroid cancer	4.5e-05	0.00304	CbGpPWpGaD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—AKT1—thyroid cancer	4.48e-05	0.00303	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—thyroid cancer	4.38e-05	0.00296	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—BRAF—thyroid cancer	4.28e-05	0.00289	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—HPGD—thyroid cancer	4.26e-05	0.00287	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SLC5A5—thyroid cancer	4.21e-05	0.00284	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—AKT1—thyroid cancer	4.2e-05	0.00283	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TPR—thyroid cancer	4.19e-05	0.00283	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—NRAS—thyroid cancer	4.18e-05	0.00282	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	4.16e-05	0.00281	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	4.15e-05	0.0028	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—thyroid cancer	4.09e-05	0.00276	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PCM1—thyroid cancer	4.07e-05	0.00275	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.06e-05	0.00274	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	4.03e-05	0.00272	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—BRAF—thyroid cancer	3.99e-05	0.00269	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	3.67e-05	0.00248	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PCM1—thyroid cancer	3.64e-05	0.00246	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—KRAS—thyroid cancer	3.59e-05	0.00243	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—TPR—thyroid cancer	3.56e-05	0.0024	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—RXRA—thyroid cancer	3.54e-05	0.00239	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.45e-05	0.00233	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—AKT1—thyroid cancer	3.42e-05	0.00231	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	3.3e-05	0.00223	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.24e-05	0.00219	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.23e-05	0.00218	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.23e-05	0.00218	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	3.22e-05	0.00217	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	3.19e-05	0.00215	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TPR—thyroid cancer	3.18e-05	0.00215	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDK1—thyroid cancer	3.18e-05	0.00215	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—thyroid cancer	3.15e-05	0.00213	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—RXRA—thyroid cancer	3.1e-05	0.0021	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—NRG1—thyroid cancer	3.06e-05	0.00207	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—HRAS—thyroid cancer	3.06e-05	0.00206	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	3.01e-05	0.00203	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—NRAS—thyroid cancer	2.88e-05	0.00195	CbGpPWpGaD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—AKT1—thyroid cancer	2.87e-05	0.00194	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDK1—thyroid cancer	2.84e-05	0.00192	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—HRAS—thyroid cancer	2.82e-05	0.0019	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PTEN—thyroid cancer	2.81e-05	0.0019	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	2.8e-05	0.00189	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	2.72e-05	0.00184	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—AKT1—thyroid cancer	2.7e-05	0.00182	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.58e-05	0.00175	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CALCB—thyroid cancer	2.53e-05	0.00171	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—thyroid cancer	2.51e-05	0.00169	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—TPR—thyroid cancer	2.49e-05	0.00168	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—KRAS—thyroid cancer	2.48e-05	0.00167	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	2.45e-05	0.00165	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—TPR—thyroid cancer	2.44e-05	0.00165	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—BRAF—thyroid cancer	2.42e-05	0.00163	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK1—thyroid cancer	2.41e-05	0.00163	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PRKAR1A—thyroid cancer	2.4e-05	0.00162	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	2.31e-05	0.00156	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MINPP1—thyroid cancer	2.28e-05	0.00154	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—thyroid cancer	2.26e-05	0.00152	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MINPP1—thyroid cancer	2.24e-05	0.00151	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TPR—thyroid cancer	2.22e-05	0.0015	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.18e-05	0.00147	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—thyroid cancer	2.17e-05	0.00147	CbGpPWpGaD
Epirubicin—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	2.16e-05	0.0268	CbGdCrCtD
Epirubicin—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	2.16e-05	0.0268	CbGdCrCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—KRAS—thyroid cancer	2.16e-05	0.00146	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDK1—thyroid cancer	2.15e-05	0.00145	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—HRAS—thyroid cancer	2.11e-05	0.00142	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	2.08e-05	0.00141	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TERT—thyroid cancer	2.05e-05	0.00138	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PRKAR1A—thyroid cancer	2.01e-05	0.00136	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—thyroid cancer	1.97e-05	0.00133	CbGpPWpGaD
Epirubicin—Shock—Sorafenib—thyroid cancer	1.97e-05	0.000462	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	1.97e-05	0.00133	CbGpPWpGaD
Epirubicin—Gait disturbance—Doxorubicin—thyroid cancer	1.97e-05	0.000461	CcSEcCtD
Epirubicin—Nervous system disorder—Sorafenib—thyroid cancer	1.96e-05	0.000461	CcSEcCtD
Epirubicin—Dizziness—Vandetanib—thyroid cancer	1.96e-05	0.00046	CcSEcCtD
Epirubicin—Thrombocytopenia—Sorafenib—thyroid cancer	1.96e-05	0.00046	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—PPARG—thyroid cancer	1.96e-05	0.00132	CbGpPWpGaD
Epirubicin—Coordination abnormal—Doxorubicin—thyroid cancer	1.95e-05	0.000458	CcSEcCtD
Epirubicin—Blood uric acid increased—Doxorubicin—thyroid cancer	1.95e-05	0.000458	CcSEcCtD
Epirubicin—Skin disorder—Sorafenib—thyroid cancer	1.94e-05	0.000456	CcSEcCtD
Epirubicin—Musculoskeletal pain—Doxorubicin—thyroid cancer	1.94e-05	0.000456	CcSEcCtD
Epirubicin—Neck pain—Doxorubicin—thyroid cancer	1.94e-05	0.000456	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—NDUFA13—thyroid cancer	1.94e-05	0.00131	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—HRAS—thyroid cancer	1.92e-05	0.0013	CbGpPWpGaD
Epirubicin—Pulmonary embolism—Doxorubicin—thyroid cancer	1.92e-05	0.00045	CcSEcCtD
Epirubicin—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	1.92e-05	0.00045	CcSEcCtD
Epirubicin—Ventricular tachycardia—Doxorubicin—thyroid cancer	1.92e-05	0.00045	CcSEcCtD
Epirubicin—Vaginal inflammation—Doxorubicin—thyroid cancer	1.92e-05	0.00045	CcSEcCtD
Epirubicin—Hepatocellular injury—Doxorubicin—thyroid cancer	1.92e-05	0.00045	CcSEcCtD
Epirubicin—Hiccups—Doxorubicin—thyroid cancer	1.92e-05	0.00045	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—thyroid cancer	1.91e-05	0.00129	CbGpPWpGaD
Epirubicin—Anorexia—Sorafenib—thyroid cancer	1.91e-05	0.000448	CcSEcCtD
Epirubicin—Injection site reaction—Doxorubicin—thyroid cancer	1.91e-05	0.000448	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—NDUFA13—thyroid cancer	1.9e-05	0.00128	CbGpPWpGaD
Epirubicin—Dermatitis contact—Doxorubicin—thyroid cancer	1.9e-05	0.000445	CcSEcCtD
Epirubicin—Abnormal dreams—Doxorubicin—thyroid cancer	1.9e-05	0.000445	CcSEcCtD
Epirubicin—Vomiting—Vandetanib—thyroid cancer	1.89e-05	0.000443	CcSEcCtD
Epirubicin—Hyperkalaemia—Doxorubicin—thyroid cancer	1.88e-05	0.000442	CcSEcCtD
Epirubicin—Eructation—Doxorubicin—thyroid cancer	1.88e-05	0.000442	CcSEcCtD
Epirubicin—Cystitis noninfective—Doxorubicin—thyroid cancer	1.87e-05	0.00044	CcSEcCtD
Epirubicin—Melaena—Doxorubicin—thyroid cancer	1.87e-05	0.00044	CcSEcCtD
Epirubicin—Rash—Vandetanib—thyroid cancer	1.87e-05	0.000439	CcSEcCtD
Epirubicin—Dermatitis—Vandetanib—thyroid cancer	1.87e-05	0.000439	CcSEcCtD
Epirubicin—Influenza like illness—Doxorubicin—thyroid cancer	1.86e-05	0.000437	CcSEcCtD
Epirubicin—Salivary hypersecretion—Doxorubicin—thyroid cancer	1.86e-05	0.000437	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—AKT1—thyroid cancer	1.86e-05	0.00126	CbGpPWpGaD
Epirubicin—Headache—Vandetanib—thyroid cancer	1.86e-05	0.000436	CcSEcCtD
Epirubicin—Cystitis—Doxorubicin—thyroid cancer	1.85e-05	0.000435	CcSEcCtD
Epirubicin—Colitis—Doxorubicin—thyroid cancer	1.84e-05	0.000432	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	1.84e-05	0.00124	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—thyroid cancer	1.83e-05	0.00124	CbGpPWpGaD
Epirubicin—Candida infection—Doxorubicin—thyroid cancer	1.83e-05	0.00043	CcSEcCtD
Epirubicin—Skin exfoliation—Doxorubicin—thyroid cancer	1.83e-05	0.00043	CcSEcCtD
Epirubicin—DHCR7—Metabolism—SLC5A5—thyroid cancer	1.83e-05	0.00124	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	1.82e-05	0.000428	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CHST14—thyroid cancer	1.82e-05	0.00123	CbGpPWpGaD
Epirubicin—Fluid retention—Doxorubicin—thyroid cancer	1.82e-05	0.000427	CcSEcCtD
Epirubicin—ABCC1—Disease—TRIM24—thyroid cancer	1.81e-05	0.00122	CbGpPWpGaD
Epirubicin—Vaginal infection—Doxorubicin—thyroid cancer	1.81e-05	0.000425	CcSEcCtD
Epirubicin—Blood urea increased—Doxorubicin—thyroid cancer	1.81e-05	0.000425	CcSEcCtD
Epirubicin—Aplastic anaemia—Doxorubicin—thyroid cancer	1.8e-05	0.000423	CcSEcCtD
Epirubicin—Neuropathy—Doxorubicin—thyroid cancer	1.8e-05	0.000423	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	1.79e-05	0.00121	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CHST14—thyroid cancer	1.79e-05	0.00121	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MINPP1—thyroid cancer	1.79e-05	0.00121	CbGpPWpGaD
Epirubicin—Dyspnoea—Sorafenib—thyroid cancer	1.78e-05	0.000419	CcSEcCtD
Epirubicin—Dry eye—Doxorubicin—thyroid cancer	1.77e-05	0.000416	CcSEcCtD
Epirubicin—Nausea—Vandetanib—thyroid cancer	1.76e-05	0.000414	CcSEcCtD
Epirubicin—Cramps of lower extremities—Doxorubicin—thyroid cancer	1.76e-05	0.000414	CcSEcCtD
Epirubicin—Dyspepsia—Sorafenib—thyroid cancer	1.76e-05	0.000413	CcSEcCtD
Epirubicin—Oesophagitis—Doxorubicin—thyroid cancer	1.75e-05	0.000411	CcSEcCtD
Epirubicin—Coma—Doxorubicin—thyroid cancer	1.75e-05	0.000411	CcSEcCtD
Epirubicin—Rash maculo-papular—Doxorubicin—thyroid cancer	1.74e-05	0.000409	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—thyroid cancer	1.74e-05	0.00118	CbGpPWpGaD
Epirubicin—Decreased appetite—Sorafenib—thyroid cancer	1.74e-05	0.000408	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	1.74e-05	0.00117	CbGpPWpGaD
Epirubicin—Neoplasm—Doxorubicin—thyroid cancer	1.73e-05	0.000407	CcSEcCtD
Epirubicin—Ecchymosis—Doxorubicin—thyroid cancer	1.73e-05	0.000407	CcSEcCtD
Epirubicin—Bladder pain—Doxorubicin—thyroid cancer	1.73e-05	0.000407	CcSEcCtD
Epirubicin—Mouth ulceration—Doxorubicin—thyroid cancer	1.73e-05	0.000407	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Sorafenib—thyroid cancer	1.73e-05	0.000406	CcSEcCtD
Epirubicin—Fatigue—Sorafenib—thyroid cancer	1.73e-05	0.000405	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.71e-05	0.00116	CbGpPWpGaD
Epirubicin—Pain—Sorafenib—thyroid cancer	1.71e-05	0.000402	CcSEcCtD
Epirubicin—Constipation—Sorafenib—thyroid cancer	1.71e-05	0.000402	CcSEcCtD
Epirubicin—Pulmonary oedema—Doxorubicin—thyroid cancer	1.71e-05	0.000401	CcSEcCtD
Epirubicin—ABCC1—Disease—CHST14—thyroid cancer	1.71e-05	0.00115	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTEN—thyroid cancer	1.7e-05	0.00115	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—AKT1—thyroid cancer	1.7e-05	0.00115	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK1—thyroid cancer	1.68e-05	0.00114	CbGpPWpGaD
Epirubicin—Hypertonia—Doxorubicin—thyroid cancer	1.68e-05	0.000395	CcSEcCtD
Epirubicin—Abnormal vision—Doxorubicin—thyroid cancer	1.67e-05	0.000393	CcSEcCtD
Epirubicin—Sepsis—Doxorubicin—thyroid cancer	1.66e-05	0.000391	CcSEcCtD
Epirubicin—Mental disability—Doxorubicin—thyroid cancer	1.66e-05	0.000391	CcSEcCtD
Epirubicin—Gastrointestinal pain—Sorafenib—thyroid cancer	1.64e-05	0.000384	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—AKT1—thyroid cancer	1.63e-05	0.0011	CbGpPWpGaD
Epirubicin—Lymphadenopathy—Doxorubicin—thyroid cancer	1.63e-05	0.000383	CcSEcCtD
Epirubicin—ABCC1—Disease—TRIM33—thyroid cancer	1.62e-05	0.00109	CbGpPWpGaD
Epirubicin—Phlebitis—Doxorubicin—thyroid cancer	1.62e-05	0.000379	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TP53—thyroid cancer	1.61e-05	0.00109	CbGpPWpGaD
Epirubicin—Thrombophlebitis—Doxorubicin—thyroid cancer	1.61e-05	0.000378	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.6e-05	0.00108	CbGpPWpGaD
Epirubicin—Diabetes mellitus—Doxorubicin—thyroid cancer	1.6e-05	0.000376	CcSEcCtD
Epirubicin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	1.6e-05	0.000376	CcSEcCtD
Epirubicin—Hepatic function abnormal—Doxorubicin—thyroid cancer	1.59e-05	0.000374	CcSEcCtD
Epirubicin—Urticaria—Sorafenib—thyroid cancer	1.59e-05	0.000373	CcSEcCtD
Epirubicin—Photosensitivity—Doxorubicin—thyroid cancer	1.59e-05	0.000372	CcSEcCtD
Epirubicin—Abdominal pain—Sorafenib—thyroid cancer	1.58e-05	0.000371	CcSEcCtD
Epirubicin—Body temperature increased—Sorafenib—thyroid cancer	1.58e-05	0.000371	CcSEcCtD
Epirubicin—PLA2G4A—Phospholipid metabolism—PTEN—thyroid cancer	1.57e-05	0.00106	CbGpPWpGaD
Epirubicin—Vascular purpura—Doxorubicin—thyroid cancer	1.56e-05	0.000365	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TERT—thyroid cancer	1.55e-05	0.00105	CbGpPWpGaD
Epirubicin—Eczema—Doxorubicin—thyroid cancer	1.55e-05	0.000364	CcSEcCtD
Epirubicin—Hepatic failure—Doxorubicin—thyroid cancer	1.55e-05	0.000364	CcSEcCtD
Epirubicin—Eye pain—Doxorubicin—thyroid cancer	1.54e-05	0.000362	CcSEcCtD
Epirubicin—DHCR7—Metabolism—RXRA—thyroid cancer	1.54e-05	0.00104	CbGpPWpGaD
Epirubicin—Cardiac failure congestive—Doxorubicin—thyroid cancer	1.54e-05	0.00036	CcSEcCtD
Epirubicin—ABCC1—Metabolism—NDUFA13—thyroid cancer	1.52e-05	0.00103	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—thyroid cancer	1.52e-05	0.00103	CbGpPWpGaD
Epirubicin—Renal failure acute—Doxorubicin—thyroid cancer	1.51e-05	0.000354	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CDK1—thyroid cancer	1.51e-05	0.00102	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.5e-05	0.00101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALCB—thyroid cancer	1.49e-05	0.00101	CbGpPWpGaD
Epirubicin—Hot flush—Doxorubicin—thyroid cancer	1.49e-05	0.000349	CcSEcCtD
Epirubicin—Increased appetite—Doxorubicin—thyroid cancer	1.48e-05	0.000348	CcSEcCtD
Epirubicin—Menopausal symptoms—Doxorubicin—thyroid cancer	1.48e-05	0.000346	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	1.48e-05	0.000346	CcSEcCtD
Epirubicin—Hypersensitivity—Sorafenib—thyroid cancer	1.47e-05	0.000346	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—HPGD—thyroid cancer	1.47e-05	0.000992	CbGpPWpGaD
Epirubicin—Renal impairment—Doxorubicin—thyroid cancer	1.46e-05	0.000343	CcSEcCtD
Epirubicin—Dermatitis bullous—Doxorubicin—thyroid cancer	1.46e-05	0.000342	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.45e-05	0.000979	CbGpPWpGaD
Epirubicin—Purpura—Doxorubicin—thyroid cancer	1.44e-05	0.000339	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—HPGD—thyroid cancer	1.44e-05	0.000973	CbGpPWpGaD
Epirubicin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	1.44e-05	0.000338	CcSEcCtD
Epirubicin—Asthenia—Sorafenib—thyroid cancer	1.44e-05	0.000337	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CHST14—thyroid cancer	1.43e-05	0.000964	CbGpPWpGaD
Epirubicin—Hypoglycaemia—Doxorubicin—thyroid cancer	1.43e-05	0.000335	CcSEcCtD
Epirubicin—Cardiac failure—Doxorubicin—thyroid cancer	1.43e-05	0.000335	CcSEcCtD
Epirubicin—Lethargy—Doxorubicin—thyroid cancer	1.42e-05	0.000333	CcSEcCtD
Epirubicin—Cerebrovascular accident—Doxorubicin—thyroid cancer	1.42e-05	0.000333	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TRIM33—thyroid cancer	1.42e-05	0.000957	CbGpPWpGaD
Epirubicin—Pruritus—Sorafenib—thyroid cancer	1.42e-05	0.000332	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.41e-05	0.000953	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	1.41e-05	0.000953	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.4e-05	0.000945	CbGpPWpGaD
Epirubicin—Hyponatraemia—Doxorubicin—thyroid cancer	1.4e-05	0.000328	CcSEcCtD
Epirubicin—Pain in extremity—Doxorubicin—thyroid cancer	1.39e-05	0.000327	CcSEcCtD
Epirubicin—Diplopia—Doxorubicin—thyroid cancer	1.39e-05	0.000327	CcSEcCtD
Epirubicin—Osteoarthritis—Doxorubicin—thyroid cancer	1.39e-05	0.000327	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	1.39e-05	0.000327	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.39e-05	0.000939	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.39e-05	0.000938	CbGpPWpGaD
Epirubicin—Affect lability—Doxorubicin—thyroid cancer	1.37e-05	0.000322	CcSEcCtD
Epirubicin—Migraine—Doxorubicin—thyroid cancer	1.37e-05	0.000322	CcSEcCtD
Epirubicin—Diarrhoea—Sorafenib—thyroid cancer	1.37e-05	0.000321	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—AKT1—thyroid cancer	1.36e-05	0.00092	CbGpPWpGaD
Epirubicin—Face oedema—Doxorubicin—thyroid cancer	1.34e-05	0.000315	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—PTEN—thyroid cancer	1.34e-05	0.000907	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IFNA2—thyroid cancer	1.33e-05	0.000898	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.32e-05	0.000894	CbGpPWpGaD
Epirubicin—Cardiac arrest—Doxorubicin—thyroid cancer	1.32e-05	0.000311	CcSEcCtD
Epirubicin—Dizziness—Sorafenib—thyroid cancer	1.32e-05	0.000311	CcSEcCtD
Epirubicin—Mood swings—Doxorubicin—thyroid cancer	1.32e-05	0.00031	CcSEcCtD
Epirubicin—Ataxia—Doxorubicin—thyroid cancer	1.31e-05	0.000307	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—KRAS—thyroid cancer	1.31e-05	0.000882	CbGpPWpGaD
Epirubicin—Blood creatinine increased—Doxorubicin—thyroid cancer	1.3e-05	0.000306	CcSEcCtD
Epirubicin—Dehydration—Doxorubicin—thyroid cancer	1.3e-05	0.000304	CcSEcCtD
Epirubicin—Liver function test abnormal—Doxorubicin—thyroid cancer	1.29e-05	0.000302	CcSEcCtD
Epirubicin—Dry skin—Doxorubicin—thyroid cancer	1.28e-05	0.0003	CcSEcCtD
Epirubicin—Vomiting—Sorafenib—thyroid cancer	1.27e-05	0.000299	CcSEcCtD
Epirubicin—Abdominal pain upper—Doxorubicin—thyroid cancer	1.27e-05	0.000298	CcSEcCtD
Epirubicin—Orthostatic hypotension—Doxorubicin—thyroid cancer	1.27e-05	0.000298	CcSEcCtD
Epirubicin—Hypokalaemia—Doxorubicin—thyroid cancer	1.27e-05	0.000297	CcSEcCtD
Epirubicin—Rash—Sorafenib—thyroid cancer	1.26e-05	0.000296	CcSEcCtD
Epirubicin—Dermatitis—Sorafenib—thyroid cancer	1.26e-05	0.000296	CcSEcCtD
Epirubicin—Breast disorder—Doxorubicin—thyroid cancer	1.26e-05	0.000295	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.26e-05	0.000848	CbGpPWpGaD
Epirubicin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	1.25e-05	0.000294	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	1.25e-05	0.000294	CcSEcCtD
Epirubicin—Headache—Sorafenib—thyroid cancer	1.25e-05	0.000294	CcSEcCtD
Epirubicin—Nasopharyngitis—Doxorubicin—thyroid cancer	1.25e-05	0.000292	CcSEcCtD
Epirubicin—Gastritis—Doxorubicin—thyroid cancer	1.23e-05	0.000289	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	1.23e-05	0.000288	CcSEcCtD
Epirubicin—Muscular weakness—Doxorubicin—thyroid cancer	1.23e-05	0.000288	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.21e-05	0.000819	CbGpPWpGaD
Epirubicin—Abdominal distension—Doxorubicin—thyroid cancer	1.21e-05	0.000284	CcSEcCtD
Epirubicin—Asthma—Doxorubicin—thyroid cancer	1.2e-05	0.000282	CcSEcCtD
Epirubicin—Dysphagia—Doxorubicin—thyroid cancer	1.2e-05	0.000282	CcSEcCtD
Epirubicin—Influenza—Doxorubicin—thyroid cancer	1.2e-05	0.000282	CcSEcCtD
Epirubicin—Eosinophilia—Doxorubicin—thyroid cancer	1.19e-05	0.00028	CcSEcCtD
Epirubicin—Nausea—Sorafenib—thyroid cancer	1.19e-05	0.000279	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CCND1—thyroid cancer	1.18e-05	0.0008	CbGpPWpGaD
Epirubicin—Pancreatitis—Doxorubicin—thyroid cancer	1.18e-05	0.000277	CcSEcCtD
Epirubicin—Angina pectoris—Doxorubicin—thyroid cancer	1.17e-05	0.000275	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—TSHR—thyroid cancer	1.17e-05	0.000791	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.17e-05	0.000789	CbGpPWpGaD
Epirubicin—YWHAG—Membrane Trafficking—AKT1—thyroid cancer	1.16e-05	0.000782	CbGpPWpGaD
Epirubicin—Bronchitis—Doxorubicin—thyroid cancer	1.16e-05	0.000272	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKAR1A—thyroid cancer	1.15e-05	0.000778	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HPGD—thyroid cancer	1.15e-05	0.000777	CbGpPWpGaD
Epirubicin—Pancytopenia—Doxorubicin—thyroid cancer	1.14e-05	0.000268	CcSEcCtD
Epirubicin—Dysuria—Doxorubicin—thyroid cancer	1.13e-05	0.000264	CcSEcCtD
Epirubicin—Neutropenia—Doxorubicin—thyroid cancer	1.13e-05	0.000264	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	1.12e-05	0.000263	CcSEcCtD
Epirubicin—Pollakiuria—Doxorubicin—thyroid cancer	1.11e-05	0.000261	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—thyroid cancer	1.11e-05	0.00075	CbGpPWpGaD
Epirubicin—Photosensitivity reaction—Doxorubicin—thyroid cancer	1.1e-05	0.000258	CcSEcCtD
Epirubicin—Weight increased—Doxorubicin—thyroid cancer	1.1e-05	0.000257	CcSEcCtD
Epirubicin—Weight decreased—Doxorubicin—thyroid cancer	1.09e-05	0.000256	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—TERT—thyroid cancer	1.09e-05	0.000733	CbGpPWpGaD
Epirubicin—Hyperglycaemia—Doxorubicin—thyroid cancer	1.09e-05	0.000255	CcSEcCtD
Epirubicin—Pneumonia—Doxorubicin—thyroid cancer	1.08e-05	0.000253	CcSEcCtD
Epirubicin—ABCC1—Disease—TCF7L1—thyroid cancer	1.08e-05	0.000728	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.07e-05	0.000726	CbGpPWpGaD
Epirubicin—Infestation—Doxorubicin—thyroid cancer	1.07e-05	0.000252	CcSEcCtD
Epirubicin—Drowsiness—Doxorubicin—thyroid cancer	1.07e-05	0.000252	CcSEcCtD
Epirubicin—Infestation NOS—Doxorubicin—thyroid cancer	1.07e-05	0.000252	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	1.06e-05	0.00025	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.06e-05	0.000714	CbGpPWpGaD
Epirubicin—Renal failure—Doxorubicin—thyroid cancer	1.05e-05	0.000248	CcSEcCtD
Epirubicin—Neuropathy peripheral—Doxorubicin—thyroid cancer	1.05e-05	0.000247	CcSEcCtD
Epirubicin—Stomatitis—Doxorubicin—thyroid cancer	1.05e-05	0.000245	CcSEcCtD
Epirubicin—Jaundice—Doxorubicin—thyroid cancer	1.05e-05	0.000245	CcSEcCtD
Epirubicin—Conjunctivitis—Doxorubicin—thyroid cancer	1.04e-05	0.000245	CcSEcCtD
Epirubicin—Urinary tract infection—Doxorubicin—thyroid cancer	1.04e-05	0.000245	CcSEcCtD
Epirubicin—Sweating—Doxorubicin—thyroid cancer	1.03e-05	0.000241	CcSEcCtD
Epirubicin—Haematuria—Doxorubicin—thyroid cancer	1.02e-05	0.00024	CcSEcCtD
Epirubicin—Hepatobiliary disease—Doxorubicin—thyroid cancer	1.01e-05	0.000238	CcSEcCtD
Epirubicin—Epistaxis—Doxorubicin—thyroid cancer	1.01e-05	0.000238	CcSEcCtD
Epirubicin—Sinusitis—Doxorubicin—thyroid cancer	1.01e-05	0.000236	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—thyroid cancer	1e-05	0.000678	CbGpPWpGaD
Epirubicin—Agranulocytosis—Doxorubicin—thyroid cancer	1e-05	0.000235	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—PTCH1—thyroid cancer	9.96e-06	0.000673	CbGpPWpGaD
Epirubicin—Bradycardia—Doxorubicin—thyroid cancer	9.81e-06	0.00023	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PPARG—thyroid cancer	9.71e-06	0.000656	CbGpPWpGaD
Epirubicin—Haemoglobin—Doxorubicin—thyroid cancer	9.68e-06	0.000227	CcSEcCtD
Epirubicin—Rhinitis—Doxorubicin—thyroid cancer	9.66e-06	0.000227	CcSEcCtD
Epirubicin—Hepatitis—Doxorubicin—thyroid cancer	9.63e-06	0.000226	CcSEcCtD
Epirubicin—Haemorrhage—Doxorubicin—thyroid cancer	9.63e-06	0.000226	CcSEcCtD
Epirubicin—Hypoaesthesia—Doxorubicin—thyroid cancer	9.59e-06	0.000225	CcSEcCtD
Epirubicin—Pharyngitis—Doxorubicin—thyroid cancer	9.56e-06	0.000224	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	9.55e-06	0.000645	CbGpPWpGaD
Epirubicin—Urinary tract disorder—Doxorubicin—thyroid cancer	9.51e-06	0.000223	CcSEcCtD
Epirubicin—Oedema peripheral—Doxorubicin—thyroid cancer	9.49e-06	0.000223	CcSEcCtD
Epirubicin—Connective tissue disorder—Doxorubicin—thyroid cancer	9.47e-06	0.000222	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TCF7L1—thyroid cancer	9.45e-06	0.000638	CbGpPWpGaD
Epirubicin—Urethral disorder—Doxorubicin—thyroid cancer	9.44e-06	0.000222	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.34e-06	0.000631	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.31e-06	0.000629	CbGpPWpGaD
Epirubicin—Visual impairment—Doxorubicin—thyroid cancer	9.28e-06	0.000218	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	9.17e-06	0.000619	CbGpPWpGaD
Epirubicin—Erythema multiforme—Doxorubicin—thyroid cancer	9.11e-06	0.000214	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—SST—thyroid cancer	9.11e-06	0.000615	CbGpPWpGaD
Epirubicin—Eye disorder—Doxorubicin—thyroid cancer	9e-06	0.000211	CcSEcCtD
Epirubicin—Tinnitus—Doxorubicin—thyroid cancer	8.98e-06	0.000211	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CCND1—thyroid cancer	8.97e-06	0.000606	CbGpPWpGaD
Epirubicin—Cardiac disorder—Doxorubicin—thyroid cancer	8.94e-06	0.00021	CcSEcCtD
Epirubicin—Flushing—Doxorubicin—thyroid cancer	8.94e-06	0.00021	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.88e-06	0.0006	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CALCA—thyroid cancer	8.77e-06	0.000592	CbGpPWpGaD
Epirubicin—Angiopathy—Doxorubicin—thyroid cancer	8.74e-06	0.000205	CcSEcCtD
Epirubicin—Immune system disorder—Doxorubicin—thyroid cancer	8.7e-06	0.000204	CcSEcCtD
Epirubicin—Mediastinal disorder—Doxorubicin—thyroid cancer	8.68e-06	0.000204	CcSEcCtD
Epirubicin—Chills—Doxorubicin—thyroid cancer	8.64e-06	0.000203	CcSEcCtD
Epirubicin—Arrhythmia—Doxorubicin—thyroid cancer	8.61e-06	0.000202	CcSEcCtD
Epirubicin—Alopecia—Doxorubicin—thyroid cancer	8.51e-06	0.0002	CcSEcCtD
Epirubicin—Mental disorder—Doxorubicin—thyroid cancer	8.44e-06	0.000198	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—TPR—thyroid cancer	8.44e-06	0.00057	CbGpPWpGaD
Epirubicin—Malnutrition—Doxorubicin—thyroid cancer	8.39e-06	0.000197	CcSEcCtD
Epirubicin—Erythema—Doxorubicin—thyroid cancer	8.39e-06	0.000197	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	8.3e-06	0.000561	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TPR—thyroid cancer	8.27e-06	0.000559	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.27e-06	0.000559	CbGpPWpGaD
Epirubicin—Flatulence—Doxorubicin—thyroid cancer	8.26e-06	0.000194	CcSEcCtD
Epirubicin—Tension—Doxorubicin—thyroid cancer	8.23e-06	0.000193	CcSEcCtD
Epirubicin—Dysgeusia—Doxorubicin—thyroid cancer	8.21e-06	0.000193	CcSEcCtD
Epirubicin—Nervousness—Doxorubicin—thyroid cancer	8.15e-06	0.000191	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PRKAR1A—thyroid cancer	8.14e-06	0.00055	CbGpPWpGaD
Epirubicin—Back pain—Doxorubicin—thyroid cancer	8.11e-06	0.00019	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.06e-06	0.000545	CbGpPWpGaD
Epirubicin—Muscle spasms—Doxorubicin—thyroid cancer	8.06e-06	0.000189	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CDK1—thyroid cancer	7.94e-06	0.000536	CbGpPWpGaD
Epirubicin—Vision blurred—Doxorubicin—thyroid cancer	7.9e-06	0.000185	CcSEcCtD
Epirubicin—ABCC1—Disease—TPR—thyroid cancer	7.89e-06	0.000533	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—thyroid cancer	7.8e-06	0.000527	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Doxorubicin—thyroid cancer	7.78e-06	0.000183	CcSEcCtD
Epirubicin—ABCC1—Disease—PRKAR1A—thyroid cancer	7.77e-06	0.000524	CbGpPWpGaD
Epirubicin—Anaemia—Doxorubicin—thyroid cancer	7.75e-06	0.000182	CcSEcCtD
Epirubicin—Agitation—Doxorubicin—thyroid cancer	7.71e-06	0.000181	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—thyroid cancer	7.64e-06	0.000516	CbGpPWpGaD
Epirubicin—Malaise—Doxorubicin—thyroid cancer	7.56e-06	0.000177	CcSEcCtD
Epirubicin—Vertigo—Doxorubicin—thyroid cancer	7.53e-06	0.000177	CcSEcCtD
Epirubicin—Syncope—Doxorubicin—thyroid cancer	7.52e-06	0.000176	CcSEcCtD
Epirubicin—Leukopenia—Doxorubicin—thyroid cancer	7.51e-06	0.000176	CcSEcCtD
Epirubicin—ABCC1—Disease—MEN1—thyroid cancer	7.42e-06	0.000501	CbGpPWpGaD
Epirubicin—Palpitations—Doxorubicin—thyroid cancer	7.41e-06	0.000174	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.38e-06	0.000498	CbGpPWpGaD
Epirubicin—Loss of consciousness—Doxorubicin—thyroid cancer	7.37e-06	0.000173	CcSEcCtD
Epirubicin—Cough—Doxorubicin—thyroid cancer	7.32e-06	0.000172	CcSEcCtD
Epirubicin—Convulsion—Doxorubicin—thyroid cancer	7.27e-06	0.000171	CcSEcCtD
Epirubicin—Hypertension—Doxorubicin—thyroid cancer	7.24e-06	0.00017	CcSEcCtD
Epirubicin—Arthralgia—Doxorubicin—thyroid cancer	7.14e-06	0.000168	CcSEcCtD
Epirubicin—Chest pain—Doxorubicin—thyroid cancer	7.14e-06	0.000168	CcSEcCtD
Epirubicin—Myalgia—Doxorubicin—thyroid cancer	7.14e-06	0.000168	CcSEcCtD
Epirubicin—Anxiety—Doxorubicin—thyroid cancer	7.12e-06	0.000167	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	7.09e-06	0.000166	CcSEcCtD
Epirubicin—Discomfort—Doxorubicin—thyroid cancer	7.05e-06	0.000166	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	7.02e-06	0.000474	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.99e-06	0.000472	CbGpPWpGaD
Epirubicin—Dry mouth—Doxorubicin—thyroid cancer	6.98e-06	0.000164	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TSHR—thyroid cancer	6.92e-06	0.000467	CbGpPWpGaD
Epirubicin—Confusional state—Doxorubicin—thyroid cancer	6.9e-06	0.000162	CcSEcCtD
Epirubicin—Oedema—Doxorubicin—thyroid cancer	6.84e-06	0.000161	CcSEcCtD
Epirubicin—Anaphylactic shock—Doxorubicin—thyroid cancer	6.84e-06	0.000161	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PRKAR1A—thyroid cancer	6.81e-06	0.00046	CbGpPWpGaD
Epirubicin—Infection—Doxorubicin—thyroid cancer	6.8e-06	0.00016	CcSEcCtD
Epirubicin—Shock—Doxorubicin—thyroid cancer	6.73e-06	0.000158	CcSEcCtD
Epirubicin—Nervous system disorder—Doxorubicin—thyroid cancer	6.71e-06	0.000158	CcSEcCtD
Epirubicin—Thrombocytopenia—Doxorubicin—thyroid cancer	6.7e-06	0.000157	CcSEcCtD
Epirubicin—Tachycardia—Doxorubicin—thyroid cancer	6.68e-06	0.000157	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTEN—thyroid cancer	6.66e-06	0.00045	CbGpPWpGaD
Epirubicin—Skin disorder—Doxorubicin—thyroid cancer	6.65e-06	0.000156	CcSEcCtD
Epirubicin—Hyperhidrosis—Doxorubicin—thyroid cancer	6.62e-06	0.000155	CcSEcCtD
Epirubicin—ABCC1—Metabolism—TPR—thyroid cancer	6.61e-06	0.000446	CbGpPWpGaD
Epirubicin—Anorexia—Doxorubicin—thyroid cancer	6.52e-06	0.000153	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—MEN1—thyroid cancer	6.51e-06	0.000439	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	6.5e-06	0.000439	CbGpPWpGaD
Epirubicin—Hypotension—Doxorubicin—thyroid cancer	6.4e-06	0.00015	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SLC5A5—thyroid cancer	6.32e-06	0.000427	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—thyroid cancer	6.28e-06	0.000424	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	6.24e-06	0.000146	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	6.22e-06	0.00042	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC5A5—thyroid cancer	6.19e-06	0.000418	CbGpPWpGaD
Epirubicin—Insomnia—Doxorubicin—thyroid cancer	6.19e-06	0.000145	CcSEcCtD
Epirubicin—Paraesthesia—Doxorubicin—thyroid cancer	6.15e-06	0.000144	CcSEcCtD
Epirubicin—Dyspnoea—Doxorubicin—thyroid cancer	6.1e-06	0.000143	CcSEcCtD
Epirubicin—Somnolence—Doxorubicin—thyroid cancer	6.08e-06	0.000143	CcSEcCtD
Epirubicin—Dyspepsia—Doxorubicin—thyroid cancer	6.02e-06	0.000141	CcSEcCtD
Epirubicin—Decreased appetite—Doxorubicin—thyroid cancer	5.95e-06	0.00014	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—thyroid cancer	5.91e-06	0.000399	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALCA—thyroid cancer	5.91e-06	0.000399	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	5.91e-06	0.000139	CcSEcCtD
Epirubicin—Fatigue—Doxorubicin—thyroid cancer	5.9e-06	0.000138	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.9e-06	0.000398	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTCH1—thyroid cancer	5.88e-06	0.000397	CbGpPWpGaD
Epirubicin—Constipation—Doxorubicin—thyroid cancer	5.85e-06	0.000137	CcSEcCtD
Epirubicin—Pain—Doxorubicin—thyroid cancer	5.85e-06	0.000137	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.8e-06	0.000392	CbGpPWpGaD
Epirubicin—Feeling abnormal—Doxorubicin—thyroid cancer	5.64e-06	0.000132	CcSEcCtD
Epirubicin—Gastrointestinal pain—Doxorubicin—thyroid cancer	5.6e-06	0.000131	CcSEcCtD
Epirubicin—Urticaria—Doxorubicin—thyroid cancer	5.44e-06	0.000128	CcSEcCtD
Epirubicin—Abdominal pain—Doxorubicin—thyroid cancer	5.41e-06	0.000127	CcSEcCtD
Epirubicin—Body temperature increased—Doxorubicin—thyroid cancer	5.41e-06	0.000127	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—SST—thyroid cancer	5.38e-06	0.000363	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDK1—thyroid cancer	5.35e-06	0.000361	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—RXRA—thyroid cancer	5.31e-06	0.000358	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—RXRA—thyroid cancer	5.2e-06	0.000351	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALCA—thyroid cancer	5.18e-06	0.00035	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.06e-06	0.000342	CbGpPWpGaD
Epirubicin—Hypersensitivity—Doxorubicin—thyroid cancer	5.04e-06	0.000118	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—NRAS—thyroid cancer	4.96e-06	0.000335	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC5A5—thyroid cancer	4.95e-06	0.000334	CbGpPWpGaD
Epirubicin—Asthenia—Doxorubicin—thyroid cancer	4.91e-06	0.000115	CcSEcCtD
Epirubicin—Pruritus—Doxorubicin—thyroid cancer	4.84e-06	0.000114	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CDK1—thyroid cancer	4.69e-06	0.000317	CbGpPWpGaD
Epirubicin—Diarrhoea—Doxorubicin—thyroid cancer	4.68e-06	0.00011	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.64e-06	0.000313	CbGpPWpGaD
Epirubicin—Dizziness—Doxorubicin—thyroid cancer	4.53e-06	0.000106	CcSEcCtD
Epirubicin—Vomiting—Doxorubicin—thyroid cancer	4.35e-06	0.000102	CcSEcCtD
Epirubicin—Rash—Doxorubicin—thyroid cancer	4.32e-06	0.000101	CcSEcCtD
Epirubicin—Dermatitis—Doxorubicin—thyroid cancer	4.31e-06	0.000101	CcSEcCtD
Epirubicin—ABCC1—Disease—NRG1—thyroid cancer	4.29e-06	0.00029	CbGpPWpGaD
Epirubicin—Headache—Doxorubicin—thyroid cancer	4.29e-06	0.000101	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—KRAS—thyroid cancer	4.27e-06	0.000288	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—RXRA—thyroid cancer	4.16e-06	0.000281	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—thyroid cancer	4.13e-06	0.000279	CbGpPWpGaD
Epirubicin—Nausea—Doxorubicin—thyroid cancer	4.07e-06	9.54e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.04e-06	0.000273	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TERT—thyroid cancer	3.86e-06	0.00026	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—thyroid cancer	3.84e-06	0.000259	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—thyroid cancer	3.79e-06	0.000256	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NRG1—thyroid cancer	3.76e-06	0.000254	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIF1A—thyroid cancer	3.69e-06	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—thyroid cancer	3.63e-06	0.000245	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TERT—thyroid cancer	3.38e-06	0.000228	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—thyroid cancer	3.35e-06	0.000226	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—thyroid cancer	3.29e-06	0.000222	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—thyroid cancer	3.23e-06	0.000218	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—thyroid cancer	3.2e-06	0.000216	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BRAF—thyroid cancer	3.05e-06	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—NRAS—thyroid cancer	2.85e-06	0.000192	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BRAF—thyroid cancer	2.68e-06	0.000181	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—thyroid cancer	2.64e-06	0.000178	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—thyroid cancer	2.63e-06	0.000177	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—thyroid cancer	2.58e-06	0.000175	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—thyroid cancer	2.47e-06	0.000167	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—thyroid cancer	2.45e-06	0.000165	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—thyroid cancer	2.3e-06	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—thyroid cancer	2.25e-06	0.000152	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—thyroid cancer	2.15e-06	0.000145	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—thyroid cancer	2.08e-06	0.000141	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—thyroid cancer	2.07e-06	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—thyroid cancer	1.95e-06	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NRAS—thyroid cancer	1.92e-06	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—thyroid cancer	1.88e-06	0.000127	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—thyroid cancer	1.84e-06	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—thyroid cancer	1.8e-06	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NRAS—thyroid cancer	1.68e-06	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—thyroid cancer	1.65e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—thyroid cancer	1.45e-06	9.77e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—thyroid cancer	1.4e-06	9.48e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—thyroid cancer	1.32e-06	8.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—thyroid cancer	1.3e-06	8.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—thyroid cancer	1.29e-06	8.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—thyroid cancer	1.24e-06	8.37e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—thyroid cancer	1.23e-06	8.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—thyroid cancer	1.09e-06	7.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—thyroid cancer	1.04e-06	7.01e-05	CbGpPWpGaD
